Expertise in
5
conditions

Dr. Edward Y. Zamrini

Neurology
Sun Health Medical Group LLC
10515 W Santa Fe Dr, 
Sun City, AZ 
Accepting New Patients
Expertise in
5
conditions
Sun Health Medical Group LLC
10515 W Santa Fe Dr, 
Sun City, AZ 

Overview

Edward Zamrini is a Neurologist practicing medicine in Sun City, Arizona.

Dr. Zamrini is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Cerebral Amyloid Angiopathy, and Parkinson's Disease.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 10 clinical trials. Dr. Zamrini is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in UT

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Sun Health Medical Group LLC
10515 W Santa Fe Dr, Sun City, AZ 85351

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drug: Solanezumab
Study Phase: Phase 3
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Enrollment Status: Completed
Publish Date: March 11, 2026
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: BIIB092
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open Label, Multicenter Study Evaluating the Imaging Characteristics of a Follow up 18F-AV-1451 Scan in Subjects That Participated in the Confirmatory Cohort of 18F-AV-1451-A05
An Open Label, Multicenter Study Evaluating the Imaging Characteristics of a Follow up 18F-AV-1451 Scan in Subjects That Participated in the Confirmatory Cohort of 18F-AV-1451-A05
Enrollment Status: Completed
Publish Date: August 24, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 2
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 23, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

42 Total Publications

Medication-Wide Association Study of Alzheimer's Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AI.
Medication-Wide Association Study of Alzheimer's Disease and Related Dementias: Identifying Drug Candidates from Electronic Health Records through Explainable AI.
Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026
Similar Doctors
Expertise in
29
conditions
Expertise in
29
conditions
Referral required
Before you request

Barrow MAMDC And Barrow Cognitive

240 W Thomas Rd, Ste 301, 
Phoenix, AZ 
 (14.7 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Marwan Sabbagh is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Sabbagh is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Lewy Body Dementia (LBD), Movement Disorders, and Deep Brain Stimulation. Dr. Sabbagh is board certified in Psychiatry & Neurology (Neurology). Dr. Sabbagh is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Neurosurgical Associates LTD.

2910 N 3rd Ave, 
Phoenix, AZ 
 (14.6 miles away)
602-406-3181
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Jadhav is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Jadhav is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Stroke, Subarachnoid Hemorrhage, Brain Aneurysm, Thrombectomy, and Stent Placement.

Expertise in
16
conditions
Expertise in
16
conditions
Referral required
Before you request

Muhammad Ali Parkinson Center

240 West Thomas Road, Suite 301, 
Phoenix, AZ 
 (14.6 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

My mission, along with the Dignity Health Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences. Dr. Shill is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Essential Tremor, Movement Disorders, Deep Brain Stimulation, and Tissue Biopsy. Dr. Shill is board certified in Psychiatry & Neurology (Neurology). Dr. Shill is currently accepting new patients.

Frequently Asked Questions about Dr. Edward Y. Zamrini

How do I make an appointment with Dr. Edward Y. Zamrini?

You can book an appointment with Dr. Edward Y. Zamrini by calling their office at 623-832-6530. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Edward Y. Zamrini a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward Y. Zamrini is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Edward Y. Zamrini specialize in?

While Dr. Edward Y. Zamrini is a Neurology, they have specific expertise in Dementia, Alzheimer's Disease, and Cerebral Amyloid Angiopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Edward Y. Zamrini participate in research or clinical trials?

Yes. Dr. Edward Y. Zamrini has published 42 articles and abstracts on conditions like Dementia. You can view a list of Dr. Edward Y. Zamrini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zamrini's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile